Abstract
IN THIS ISSUE OF SLEEP A LETTER TO THE EDITOR APPEARS FROM DAUVILLIERS AND COLLEAGUES1 REPORTING A POSSIBLE ASSOCIATION BETWEEN narcolepsy-cataplexy and H1N1 exposure believed to be primarily through the vaccine Pandemrix2 (GlaxoSmithKline), which contained the adjuvant ASO39. This report follows an earlier observation of an association by Swedish authorities, which led to the suspension of the use of this vaccine in Sweden and Finland.3

This publication has 2 references indexed in Scilit: